We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 May 2024) launched AI Airlock, its new regulatory sandbox for AI as a Medical Device (AIaMD).
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Almost three years on from the approval in the UK of the first COVID-19 vaccine, the Medicines and Healthcare products Regulatory Agency (MHRA) pays tribute to the scientists who developed the technology behind the mRNA COVID vaccines, Dr Katalin Kariko...
Government outlines action to make UK a world leader in tackling ethnic and other biases in medical devices.
News and guidance on veterinary medicines issues affected by coronavirus (COVID-19).
The MHRA welcomes the publication of Dame Margaret Whitehead’s Equity in Medical Devices: Independent Review
Patients requiring treatment outside of hospitals will be able to choose between multiple providers across the NHS and independent sector.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
The successful five winners of a brand new challenge from a collaboration of regulators and healthcare organisations in the UK and US have been announced today (10 January 2024). The challenge saw 25 teams of artificial intelligence and machine learning...
Both parties have agreed a preferred mediator - the union and the government will now begin the process of engaging with them.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
The government has funded 350 additional medical school places in England for the academic year 2025 to 2026 in latest step to deliver NHS Long Term Workforce Plan.
News and consultations from the Fish Health Inspectorate about disease outbreaks and policy changes which affect the aquaculture industry
Advice and guidance on the health needs of migrant patients from Eritrea for healthcare practitioners.
Backed by a new award of £1.8 million, the Medicines and Healthcare products Regulatory Agency (MHRA) is to establish a dedicated team to provide regulatory scientific support for innovators creating novel antimicrobials and diagnostics as part of a programme led...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).